Prediction of Cardiovascular and All-Cause Mortality After Myocardial Infarction in US Veterans

Bing Lu1, Daniel Posner2, Jason L Vassy3

  • 1Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Veterans Affairs, Boston Healthcare System, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, Connecticut.

Insights

New risk models predict cardiovascular disease (CVD) death and all-cause mortality in myocardial infarction (MI) survivors. These models identify key risk factors and can guide secondary prevention strategies for improved patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Informatics

Background:

  • Existing cardiovascular disease (CVD) death risk models may not accurately predict outcomes for myocardial infarction (MI) survivors.
  • Accurate mortality risk prediction post-MI is crucial for effective secondary prevention strategies.

Purpose of the Study:

  • To develop and internally validate risk prediction models for 5-year CVD death and all-cause mortality in outpatient MI survivors.
  • To identify predictors associated with increased or decreased mortality risk in this patient population.

Main Methods:

  • Utilized national electronic health record data from the Veterans Health Administration (2002-2012).
  • Developed Cox proportional hazards models using follow-up data of 100,601 MI survivors.
  • Evaluated model performance using a cross-validation approach.

Main Results:

  • Identified key risk factors for CVD and all-cause death in men, including older age, smoking, heart failure, and peripheral artery disease.
  • Statin and hypertension medication use, higher estimated glomerular filtration rate, and higher body mass index were associated with reduced mortality risk.
  • Similar, yet distinct, predictors were observed in women; models demonstrated good calibration and predictive accuracy (C-statistics ranging from 0.75 to 0.81).

Conclusions:

  • Developed and validated 5-year risk prediction models for CVD and all-cause death in MI survivors.
  • Traditional risk factors, comorbidities, and undertreatment of hypertension and hyperlipidemia significantly increase mortality risk.
  • These models can aid in tailoring secondary prevention for MI survivors.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
388
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
29
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80